Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

P Moreau, M Attal, C Hulin, B Arnulf, K Belhadj, L Benboubker, A. Broijl, H Avet-Loiseau, Pieter Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

370 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)29-38
Number of pages10
JournalLancet (UK)
Volume394
Issue number10192
DOIs
Publication statusPublished - 2019

Cite this